Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
BioAccess LAbioaccessla.combioaccess is a contract research organization (CRO) specializing in first-in-human (FIH) clinical trials for MedTech, Biopharma, and Radiopharma startups, with U.S. regulatory anchoring and execution across Latin America. Founded in 2010 by Harvard-trained physicians, it offers faster ethics approvals (4–8 weeks) and lower per-patient costs ($15K–$35K) compared to US/EU trials.
Parse Score
